Pulling SEC filings + quote and writing the call…

LGI Homes, Inc.
Next earnings Aug 3, 2026 · consensus $0.85 EPS, $472M rev
Last earnings +8.0% on 2026-04-28
Cyclical homebuilder in a sharp downturn but trading at ~0.7x book — asset value floors it; deteriorating earnings cap it.
Revenue (FY2025) $1.71B · FY2025
Middling fundamentals and a rich price (~63% above fair value) leave little margin of safety — a wait-and-see.
LGIH is a textbook cyclical caught mid-downturn. FY2025 home sales revenue fell 22.6% to $1.71B as closings dropped 22.3% to 4,685 homes, and profitability collapsed far faster: net income -63.0% to $72.6M and diluted EPS -62.4% to $3.12. The damage is in the margin, not just volume — gross margin compressed to 20.7% from 24.2% and operating income fell 62.4% to $79.8M (4.7% margin), dragging ROE down to an unimpressive 3.5%. The four-year revenue arc ($3.05B in 2021 → $1.71B in 2025) confirms this is a multi-year contraction, and management is shrinking the engine ahead of it: active communities -4.6% to 144 and total owned/controlled lots -14.2% to 60,842, signaling a deliberate pullback rather than a one-quarter air pocket.
The balance sheet is the swing factor and it is mixed. Equity is solid at $2.10B against $1.83B of liabilities (0.87x), but quality is eroding at the edges: long-term debt rose 11.9% to $1.66B while cash sits at just $61.2M, and operating cash flow was -$140M for the year. For a builder, negative OCF can reflect land/inventory investment, but here it is happening alongside a shrinking lot pipeline and rising leverage — that is cash burn into a downturn, not growth investment, and it limits flexibility. The 10-K's risk language leans hard on impairment judgment ('we cannot predict if future impairments will occur') and discount-rate sensitivity, a tell that inventory and land-option carrying values are under pressure if demand stays soft.
Is LGIH a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.05B | $2.30B | $2.36B | $2.20B | $1.71B |
| Gross profit | — | — | — | — | — |
| Operating income | $548M | $390M | $233M | $212M | $79.8M |
| Net income | $430M | $327M | $199M | $196M | $72.6M |
| Diluted EPS | $17.25 | $13.76 | $8.42 | $8.30 | $3.12 |
| Net margin | 14.1% | 14.2% | 8.4% | 8.9% | 4.3% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Changed certifying accountant (auditor) under Item 4.01; routine exhibits
Q1 2026 10-Q; margin compression and lower closings persist
Q1 2026 10-Q; margin compression and lower closings persist
Annual meeting vote results disclosed; directors elected, routine
2026 proxy: board, exec pay and AGM agenda; no financial surprise
FY2025 10-K: revenue -23% to $1.71B, gross margin 20.7% vs 24.2%, EPS $3.12
FY2025/Q4 results: revenue -23%, net income -63% YoY
Q3 2025 10-Q; declining closings, margins and earnings YoY
Q3 2025 10-Q; declining closings, margins and earnings YoY
Sources: SEC EDGAR (CIK 0001580670, latest 10-Q filed 2026-04-28) · EODHD · Proprietary analysis · as of 6/30/2026, 9:56:04 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 5:56 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-03-09 | Snider Michael Larry President and COO | Sell | 5.60K @ $41.54 | $233K |
| 2026-03-09 | Snider Michael Larry President and COO | Sell | 404.00 @ $42.55 | $17.2K |
| 2026-03-09 | Snider Michael Larry President and COO | Sell | 1.88K @ $43.41 | $81.7K |
| 2026-03-09 | Snider Michael Larry President and COO | Sell | 4.26K @ $41.54 | $177K |
| 2026-03-09 | Snider Michael Larry President and COO | Sell | 307.00 @ $42.55 | $13.1K |
| 2026-03-09 | Snider Michael Larry President and COO | Sell | 1.43K @ $43.41 | $62.1K |
| 2026-03-09 | Merdian Charles Michael CFO and Treasurer | Sell | 5.12K @ $41.54 | $213K |
| 2026-03-09 | Merdian Charles Michael CFO and Treasurer | Sell | 369.00 @ $42.55 | $15.7K |
| 2026-03-09 | Merdian Charles Michael CFO and Treasurer | Sell | 1.72K @ $43.41 | $74.7K |
| 2026-03-09 | Lipar Eric Thomas CEO and Chairman of the Board | Sell | 17.7K @ $41.54 | $735K |
| 2026-03-09 | Lipar Eric Thomas CEO and Chairman of the Board | Sell | 1.27K @ $42.55 | $54.2K |
| 2026-03-09 | Lipar Eric Thomas CEO and Chairman of the Board | Sell | 5.94K @ $43.41 | $258K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
4 buys · 1 sell · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.